METHODES D'UTILISATION D'ANTAGONISTES DE VASOPRESSINE AVEC DES AGENTS CHIMIOTHERAPEUTIQUES A BASE D'ANTHRACYCLINE VISANT A REDUIRE LA CARDIOTOXICITE ET/OU AMELIORER LA SURVIE
The present invention relates to methods of reducing cardiotoxicity and/or improving survival from treatment with anthracycline agents comprising administering a therapeutically effective amount of a composition comprising a vasopressin antagonist compound or a pharmaceutically acceptable salt thereof as an active ingredient, administered simultaneously or prior to the anthracycline administration.